AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05668845 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: PG-ANB performed at the end of the LSG
Description: The paragastric lesser omentum neural block is performed with a 25-gauge needle attached to a venous catheter extension introduced through the left 12-mm port. The needle is capped during its introduction, and the cap is removed inside the abdomen using a grasper and kept under direct vision. Infiltration of 20 mL of non-diluted 0.5% bupivacaine is performed at six levels with careful aspiration preceding fluid infiltration. Four areas are adjacent to the vagus nerves and branches, and two are in the vicinity of the common hepatic and left gastric arteries. This is performed at the end of the LSG>
Study NCT05726786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Immunonutrition
Description: Immunonutrition: Oral Impact®, Nestlé Health Science, Switzerland.~IN will be administered as per manufacturer suggestion, i.e. three times a day during 7 days preoperatively. Oral Impact® is a powdered oral feed that provides 309 kcal/bag
Study NCT05985629 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPACK
Description: Infiltration between the popliteal artery and capsules of the knee (IPACK) is a novel ultrasound-guided technique that provides additional regional analgesic relief to the posterior aspect of the knee without complications seen in a sciatic nerve block. The intention of the IPACK block is to anesthetize the terminal sensory nerves while sparing the main trucks of the common peroneal and tibial nerves.
Study NCT05985629 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: PLACEBO
Description: The control group will receive the normal pre-procedure care including a pre-operative visit, surgery, and post-operative care. The control group will receive a sham block consisting of saline in the same anatomical location and manner that the intervention IPACK block is administered.
Study NCT05084482 — intervention group
Intervention type: OTHER
Intervention: Prediction models
Description: The prediction scores are validated by the CAM-ICU scores up to 14 days after ICU admission.
Study NCT05584189 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Rapid SARS-CoV-2 Antigen Test
Description: Candidate Ag self-test kit anterior nasal specimen collection and testing will be done under the supervision of qualified site personnel in person.
Study NCT06456281 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: A noninvasive cfDNA multi-omics assay
Description: Peripheral venous blood samples will be collected from pancreatic cancer patients, individuals with precancerous lesions, and healthy controls. Subsequently, cfDNA will be extracted and subjected to low-pass whole genome sequencing (LP-WGS) and hybrid capture-based targeted methylation sequencing (TMS).
Study NCT04379401 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Cardiac Resynchronization Therapy (ON vs. OFF)
Description: This study involves study participants, who already received cardiac resynchronisation therapy implantation for clinical reasons. CRT is authorized for medical use by Swissmedic in Switzerland and all implanted devices are CE-approved.
Study NCT05352425 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MobiusHD
Description: The MobiusHD® device is a nickel-titanium device that is implanted in the internal carotid sinus using a minimally invasive approach.
Study NCT05993676 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: MeT4VeT mobile phone app: control
Description: The control/ sham comparator arm of the Mental Health Toolkit for Veterans (MeT4VeT) smart phone app contains only signposting information around support services available to military veterans
Study NCT05993676 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: MeT4VeT mobile phone app: intervention
Description: The Mental Health Toolkit for Veterans (MeT4VeT) smart phone app has been developed through careful and close collaboration with military veterans and key providers of veterans' mental healthcare services. The aim of this app is to provide both a degree of education to support military veterans' understanding of mental health and foster self-recognition and management of mental health symptoms whilst also encouraging those who need it to seek more formal support.~The elements of the app have been chosen for inclusion as they represent the intersection between:~1. Core components of cognitive behavioural therapy, the theoretical framework underwriting the app~2. Behaviour change constructs
Study NCT06065826 — intervention group
Intervention type: OTHER
Intervention: Assessment
Description: All subjects will be assessed for FHP by taking a lateral view picture to calculate the CVA using the Kinovea software. Each subject with FHP will be examined for myofascial trigger points done by the therapist finger to palpate bilaterally on tender nodules in masticatory and neck muscles. Then using a pressure algometer, the PPT value will be scored for each trigger in each muscle bilaterally. Masticatory muscle endurance will be measured by asking the subject to bite on load sensor for as long as the subject can until exhaustion. Using a stopwatch, the time will be recorded in seconds. Using the craniocervical extension endurance test, the subject will lie prone with their head unsupported and with a bubble inclinometer attached to their head. Using a stopwatch, time in seconds will be recorded to test how long the subject can sustain the neck in neutral position. Finally, a smartphone addiction scale will be answered by the subject to identify how much they are addicted to its use.
Study NCT04848935 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CURATE.AI
Description: CURATE.AI will be utilised to provide personalised training intensity recommendations (low, medium or high) to the patients during the digital cognitive test battery DI session. The difficulty of each task will be modulated by CURATE.AI by adjusting the frequency of critical events that demand evaluation and/or response.
Study NCT04068493 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Project Health
Description: A dissonance-based obesity intervention consisting of eight weekly groups sessions (1.5 hours).
Study NCT06199791 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lamotrigine 100 MG
Description: tablets
Study NCT06199791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lamotrigine 100 MG
Description: tablets
Study NCT05175040 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prophylactic manual rotation
Description: Prophylactic manual rotation, performed in the experimental arm, involves a vaginal examination performed with an obstetric provider's hands to turn the baby from a position in which the baby's face is looking up in the direction of the ceiling (occiput posterior) or to the side (occiput transverse) to a position in which the baby's face is looking down in the direction of the mother's spine (occiput anterior). Prophylactic manual rotation will occur at the initiation of pushing once the individual achieves complete cervical dilation, performed by a trained study investigator (M.D. or midwife) to maintain blinding of the patient's primary obstetrician.
Study NCT05175040 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham rotation
Description: Sham rotation, performed in the comparator arm, involves a vaginal exam that obstetric providers commonly do with their hands to assess cervical dilation and fetal position during routine labor, and will occur at the initiation of pushing once the individual achieves complete cervical dilation. Duration of the vaginal exam for sham rotation will be consistent with that used for prophylactic manual rotation and will be performed by a trained study investigator (M.D. or midwife) to maintain blinding of the patient's primary obstetrician.
Study NCT05119751 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tree 12 SQ-Bet
Description: DAILY DOSE OF AIT TABLET
Study NCT05091268 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: All participants will attend a four-hour pain education session including gynecologist, psychologist, sexologist, and physiotherapist at Akershus University Hospital.~The education will be held twice, with half of the participants at the time. The training group will then attend a 60 minutes weekly group training session led by a physiotherapist with specialist training in women's health over a period of four months. In addition, participants will perform a progressive home exercise program performed daily over the same period. The focus will be general strength training using own body weight and cardiovascular fitness (walking, low-impact aerobic exercise), stretching, and relaxation
Study NCT05814952 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: LX103 Injection
Description: Qualified subjects will receive a single unilateral intravitreal injection of LX103 at Day 0 in the trial.
Study NCT06262841 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Piezosurgery
Description: Piezosurgery used as an osteotomy device
Study NCT05119751 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: GRASS 2800 BAU
Description: DAILY DOSE OF AIT TABLET
Study NCT05119751 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: RAGWEED 12 AMB A 1-U
Description: DAILY DOSE OF AIT TABLET
Study NCT05119751 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: HDM 12 SQ-HDM
Description: DAILY DOSE OF AIT TABLET
Study NCT05615948 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: VTS-K
Description: Proprietary oral formulation of 486mg aspirin and 80mg ketamine
Study NCT05386368 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: ReCell
Description: The perioral area of the face will be treated with CO2 laser. Randomization would occur before study initiation with subjects assigned either left perioral or right perioral RECELL treatment based on their subject enrollment number. The study team member who prepares and blinds the RECELL will create the list of subject ID numbers with subject ID number randomly assigned to either left perioral or right perioral treatment group. This will be completed prior to any patient enrollment in the study. Intraoperatively, RECELL and Placebo will be provided to surgeons and assistants in opaque application devices prepared by a trained, designated study team member.~Both the treatment and placebo sides, will be dressed with a standard autologous cell suspension post treatment dressing (Telfa Clear and Xeroform).
Study NCT05642598 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pivot for Vape
Description: Pivot for Vape vaping cessation smartphone app and program
Study NCT06469437 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Providing the physicians with a proposed glycated hemoglobin target
Description: Through the geriatric assessment, the investigators will categorize the groups proposed by the Diabetes Canada Clinical Practice Guidelines Expert Committee guideline recommendations into functionally independent, functionally dependent and frail. The investigators will provide the physician with the glycated hemoglobin target proposed by the guideline.
Study NCT05907031 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: active continuous Theta Burst Stimulation
Description: Each patient will receive two 600-pulse cTBS stimulations per day, parted by a 15-minute rest period (a total of 1200 pulses daily), for 3-week treatment, with 5 consecutive days each week.
Study NCT05907031 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: sham continuous Theta Burst Stimulation
Description: Each patient will receive two sham 600-pulse cTBS stimulations per day, parted by a 15-minute rest period (a total of 1200 pulses daily), for 3-week treatment, with 5 consecutive days each week.
Study NCT05780957 — intervention group
Intervention type: OTHER
Intervention: MCED
Description: multi-cancer early detection (MCED) test
Study NCT05404321 — intervention group
Intervention type: OTHER
Intervention: Establishment of ex vivo breast cancer organoid models
Description: This study includes 2 steps: The constitution of a collection of tumor and blood samples and the analysis of the ex vivo response of the tumor samples to the treatments for the development of functional tests and the research of predictive biomarkers of this response
Study NCT05048329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Non-invasive continuous remote monitoring with structured escalation pathway
Description: Continuous patient monitoring through non-invasive biosensors coupled with machine learning algorithms, with a structured escalation and communication pathway for home health providers and colorectal clinical team
Study NCT05048329 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Affective Analysis of Participant Response to Continuous Remote Patient Monitoring
Description: Surveys and interviews with enrolled participants
Study NCT05343936 — intervention group
Intervention type: OTHER
Intervention: Active surveillance
Description: The active surveillance protocol involves a TRUS prostate biopsy at eligibility, at 12 months and then every two years. MRI with or without biopsy at eligibility and then every two years. Clinical evaluation with digital rectal examination and PSA every 6 months. Every year a quality of life and anxiety evaluation are planned.~A new prostate biopsy is indicated if biochemical progression by PSA or changes in multiparametric MRI. Triggers for definitive intervention are biopsy pathological reclassification with Gleason score greater than 6, clinical progression or patient's request.
Study NCT05723939 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Carnosine supplementation
Description: Intake of carnosine supplement in form of capsules or functionally enriched chicken meet for three weeks
Study NCT05723939 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Controls
Description: Intake of placebo capsules or regular chicken meet for three weeks
Study NCT06191588 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: INFANT CIMT/BIT
Description: Constraint induced movement therapy (CIMT) and Bimanual Intensive therapy (BIT)
Study NCT06191588 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: INFANT CIMT/BIT
Description: Constraint induced movement therapy (CIMT) and Bimanual Intensive therapy (BIT)
Study NCT06550557 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: counselling sessions
Description: the counselling sessions were adopted from the health belief model with the cues of action depending on mobile phones as muting notifications, removing social media and using computers instead if possible.
Study NCT04999657 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Non-invasive low-frequency tibial nerve stimulator (TNS-01)
Description: The investigational device is a transcutaneous electrical nerve stimulation (TENS) device that is designed to provide stimulation to the nerves at the site of application via surface electrodes temporarily adhered to the skin.
Study NCT04999657 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Non-invasive low-frequency tibial nerve stimulator (TNS-01)
Description: The investigational device is a transcutaneous electrical nerve stimulation (TENS) device that is designed to provide stimulation to the nerves at the site of application via surface electrodes temporarily adhered to the skin.
Study NCT05283161 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cannabidiol and tetrahydrocannabinol
Description: CBD and THC will be given in the same concentration within a group of 10 participants, while its effects will be compared with the other two groups with 10 participants each and the placebo group.
Study NCT05283161 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo will match the study drug in odor, taste, color and appearance to ensure proper masking.
Study NCT05095844 — intervention group
Intervention type: BIOLOGICAL
Intervention: vaccinated
Description: Pfizer-BioNTech COVID-19 Vaccine, Moderna or J\&J/Janssen COVID-19 Vaccine, Diphtheria (e.g., DTP, DTaP, Tdap, DT, Td, TT) Haemophilus influenza type b polysaccharide conjugate vaccines (e.g., Hib) Hepatitis A (e.g., HAV) Hepatitis B (e.g., HBV) Human papillomavirus (e.g., HPV) Seasonal influenza (e.g., Flu) Measles (e.g., MMR) Mumps (e.g., MMR, MR, M) Meningococcal (e.g., MCV4, MPSV4, MenB-FHbp, MenB-4C) Pertussis (e.g., DTP, DTaP, Tdap) Pneumococcal conjugate (e.g., PCV) Polio (e.g., OPV or IPV) Rotavirus (e.g., RV) Rubella (e.g., MMR, MR, R) Tetanus (e.g., Td) Varicella (e.g., VAR)
Study NCT05825456 — intervention group
Intervention type: PROCEDURE
Intervention: endoprosthetic reconstruction
Description: This is a type of surgery in which the affected part of the bone and joint is removed, and replaced by a prosthesis.
Study NCT05825456 — intervention group
Intervention type: PROCEDURE
Intervention: Intramedullary nailing
Description: This is a type of surgery in which the affected bone is stabilized by a nail. The affected part could be removed or retained. If removed, the defect is filled with bone cement.
Study NCT06262841 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional burs
Description: Conventional burs used as an osteotomy device
Study NCT05825456 — intervention group
Intervention type: PROCEDURE
Intervention: Open reduction internal fixation with plate and screws
Description: This is a type of surgery in which the affected part of the bone is visualized completely, after the reduction is achieved, the fixation is provided with appropriate plates and screws. Again the affected part could be removed or retained. If removed, the defect is filled with bone cement.
Study NCT04836299 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivermectin
Description: Participants will be randomly assigned to receive a single 600 µg / kg dose of ivermectin or placebo.
Study NCT04836299 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will be randomly assigned to receive a single of placebo.
Study NCT05077943 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Breathing and chest mobilization exercises
Description: Patients walk regularly 5 times per week and increase the distance day by day according to their improved ability. Patients also do breathing and chest mobilization exercise 3 times per week. It is a recorded moderated exercise for 30 minutes duration. Patients can access the video as a home-based activity through an online videos platform and will be supervised.
Study NCT05440227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PG2 Lyo. Injection 500mg
Description: PG2 Lyo. Injection 500mg (reconstituted with 0.9% normal saline 500ml) will be administered weekly for 8 weeks.
Study NCT05440227 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo 0.9% normal saline
Description: 0.9% normal saline 500ml will be administered weekly for 8 weeks.
Study NCT05666466 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: extratympanic electrocochleograhy
Description: electrophysiological test
Study NCT05077943 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Second phase cardiac rehabilitation
Description: Independently, patients walk regularly 5 times per week and increase the distance day by day according to their improved ability without breathing and chest mobilization exercise.
Study NCT03458611 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Active Intervention
Description: An audiovisual expanding (looming) stimulus is presented repeatedly to patients during the intervention (Dent \& Humphreys, 2011). During the game a disk is presented to the player. This disk expands and contracts in size. The presentation of the disk coincides with the presentation of a sound that matches in frequency. The disk predicts the location where the next target will be presented. The player must discriminate between two types of target stimuli that are presented at the center of the disk. To discriminate between the two targets, the player receives a limited time window. The location of the disk and target stimuli are adjusted in real-time as a function of the player's performance. The primary goal of this algorithm is to present the multisensory looming stimuli more frequently in the contralesional field than in the ipsilesional field.
Study NCT03458611 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Placebo Intervention
Description: The active and placebo intervention are identical in all aspects except for the fact that stimulus presentation will be located in the center of the visual field.
Study NCT06552039 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Polyherbal Hair Oil
Description: Apply oil with the help of fingertips on your scalp and massage it gently enabling it to penetrate into the roots (follicle) of your hair. Don't apply with your palms and never rub it vigorously as it may uproot weak hair. Let the oil gradually seep into follicle of your hair \& nourish them for the whole night. The oil may be removed in the morning by washing of hair with Ayurvedic Shampoo. Dosage form: liquid frequency: Three times a week Route of Administration: Topical
Study NCT06552039 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Minoxidil Herbal Hair Oil + Minoxidil 5 (%) Hair Serum
Description: First, apply the herbal hair oil generously to your scalp and hair, ensuring thorough coverage. Gently massage it in with your fingertips to promote circulation and absorption. After the oil application, follow the instructions provided for the application of the minoxidil hair serum. Apply the serum to the areas of your scalp where you desire hair growth, using the dropper provided or as directed. Massage it gently into your scalp to ensure even distribution and absorption. Leave the serum on without rinsing.~Dosage form: liquid Frequency : For Minoxidil - Daily Night Application For Herbal Hair Oil- Thrice a week.~Route of Administration: Topical
Study NCT06552039 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Minoxidil Hair Serum
Description: Apply the amount prescribed to the area of the scalp being treated, beginning in the center of the area. Dosage form: liquid Frequency : Daily night Application of Minoxidil Route of Administration: Topical